New dengue vaccine for UK travellers: recommended only for those with a previous infectionAngela McBrideNicky LongleyJane OsborneTommy RamplingCatherine F HoulihanThe Lancet Microbe
As the COVID-19 pandemic affected vaccine intention worldwide, we assessed dengue vaccine intention before (pre-COVID) and after (post-COVID) COVID-19 vaccine availability among participants enrolled in the Communities Organized to Prevent Arboviruses (COPA) cohort to prepare for dengue vaccine ...
The vaccine strains for DENV-1, DENV-3, and DENV-4 used to formulate tetravalent DENVax vaccine were generated by replacing the pre-membrane (prM) and envelope (E) genes from the DENV-2 PDK53-V strain, with the prM and E genes from wild-type DENV strains [27]. The chimeric DENVax ...
However, this vaccine might be expected to express different epitopes in varying proportions, depending on the 'dose' of each +PHGEVKQP 'CTN[XKTCGOKC .QYQTPQPG &KUGCUG 5WDENKPKECN r.GUUXKTWNGPVXKTWUUVTCKP r*QUVIGPGVKETGUKUVCPEG r0GWVTCNK\KPICPVKDQF[ r'CTN[+...
Center for Vaccine Development, Mahidol University Institute of Science & Technology for Development, 25/25 Phutthamonthon 4 Road, Salaya, 73170, Nakhon Pathom, Thailand Sutee Yoksan London School of Hygiene and Tropical Medicine, Dept of Clinical Research, Keppel Street, London, WC1E 7HT, UK ...
Dengue is one of the most frequently transmitted viral infections globally which creates a serious burden to the healthcare system in many countries in the tropical and subtropical regions. To date, no vaccine has demonstrated balanced protection against the four dengue serotypes. Dengvaxia as the ...
In addition, Qdenga® and the inactivated hepatitis A virus vaccine can be co-administered. In a parallel randomized trial involving 900 UK adults aged 18–60 years, the co-administration of hepatitis A vaccine with the first dose of Qdenga® similarly resulted in preserved immunogenicity of...
At present, there is no particular treatment or vaccine candidate available for dengue infection. Approximately 3.9 billion human populations are at risk of dengue virus (DENV) infection. Thus, precise diagnosis of dengue at the early stage is very essential for disease control and effective therapy...
Dengue fever regardless of its serotypes has been the most prevalent arthropod-borne viral diseases among the world population. The development of a dengue vaccine is complicated by the antibody-dependent enhancement effect. Thus, the development of a pl
UK Nivarthi, J Swanstrom, MJ Delacruz, et al. A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans Nat Commun, 12 (2021), Article 1102 View in ScopusGoogle Scholar Cited by (2) Exploring plant-based dengue therapeutics: from laboratory...